Cargando…
Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age group and is associated with a higher cardiovascular risk. Obesity, mainly visceral adiposity, is prevalent in patients with PCOS. Obesity is associated with low-grade inflammation and raised inflammatory cy...
Autores principales: | Sathyapalan, Thozhukat, Atkin, Stephen L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852606/ https://www.ncbi.nlm.nih.gov/pubmed/20396393 http://dx.doi.org/10.1155/2010/758656 |
Ejemplares similares
-
Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
por: Kahal, Hassan, et al.
Publicado: (2011) -
Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
por: Alalami, Huda, et al.
Publicado: (2018) -
A review of therapeutic options for managing the metabolic aspects of
polycystic ovary syndrome
por: Abdalla, Mohammed Altigani, et al.
Publicado: (2020) -
Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013) -
Components of the Complement Cascade Differ in Polycystic Ovary Syndrome
por: Butler, Alexandra E., et al.
Publicado: (2022)